Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of 2-iminobiotin in term neonates with moderate to severe perinatal asphyxia
2011-002502-74Phase 2Terminated
- Sponsor
- Neurophyxia
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asphyxia neonatorum and hypoxic-ischemic encephalopathy (HIE) comparing 2-iminobiotin with Placebo (2 arms). Primary endpoint: Primary efficacy outcome (MRS and survival with aEEG). Started Aug 2011; status: terminated.
02
Drugs
2-iminobiotin
03
Conditions
asphyxia neonatorumhypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on 2011-002502-74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002502-74.